Search Results - "Lachant, Daniel"

Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS‐CoV‐2 infection by Lachant, Daniel J., Lachant, Neil A., Kouides, Peter, Rappaport, Stephen, Prasad, Paritosh, White, R James

“…Background Thrombotic disease complicates severe SARS‐CoV‐2 infection and is associated with increased morbidity and mortality. Various anticoagulation…”
Get full text

Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes? by Korman, Benjamin D, Lachant, Daniel J, Castelino, Flavia V

“…Pulmonary hypertension (PH) is a leading cause of morbidity and mortality in systemic sclerosis (SSc). PH is a heterogenous condition and several different…”
Get full text

Selexipag Use in Clinical Practice: Mind the Gap by White, R. James, Lachant, Daniel J.

Get full text

Risk scores as a surrogate in pulmonary arterial hypertension: a different lens by White, R James, Lachant, Daniel J, Benza, Raymond L

Get full text

Resting heart rate as a surrogate for improvement in intermediate risk pulmonary embolus patients? by Roto, Dominick, Lachant, Neil A., James White, R., Lachant, Daniel J.

“…Pulmonary embolism (PE) response teams (PERT) have been developed to improve in-hospital mortality. Identifying intermediate risk PE patients that will…”
Get full text

Combination therapy improves vascular volume in female rats with pulmonary hypertension by Lachant, Daniel J, Meoli, David F, Haight, Deborah, Staicu, Serban, Akers, Shanti, Glickman, Samuel, Ambrosini, Robert, Champion, Hunter C, White, R James

“…Pulmonary arterial hypertension (PAH) is a female predominant disease in which progressive vascular remodeling and vasoconstriction result in right ventricular…”
Get more information

An untapped resource: characteristics of thrombus recovered from intermediate or high risk pulmonary embolus patients by Newcomb, Geoffrey, Wilson, Bennett L, White, R James, Goldman, Bruce, Lachant, Neil A, Lachant, Daniel J

“…•Little is known about acute pulmonary embolism histology in survivors.•In thrombus obtained during acute embolectomy there was varying age of clots.•The age…”
Get full text

Cardiac effort and 6‐min walk distance correlate with stroke volume measured by cardiac magnetic resonance imaging by Lachant, Daniel J., Lachant, Michael D., Haight, Deborah, White, R. James

“…Right ventricular (RV) dysfunction in pulmonary arterial hypertension (PAH) is associated with poor outcomes. Cardiac magnetic resonance imaging (cMRI) is the…”
Get full text

CMV Encephalitis/Radiculitis: The Difficulty in Diagnosing in an Intubated Patient by Newcomb, Geoffrey, Lachant, Daniel J., Mariuz, Peter

“…Cytomegalovirus (CMV) can cause severe disease including colitis, pneumonitis, and less commonly encephalitis, in profoundly immunocompromised individuals. CNS…”
Get full text

Nasopharyngeal viral PCR in immunosuppressed patients and its association with virus detection in bronchoalveolar lavage by PCR by Lachant, Daniel J., Croft, Daniel P., McGrane Minton, Heather, Prasad, Paritosh, Kottmann, Robert M.

“…ABSTRACT Background and objective Pulmonary infiltrates are common in immunosuppressed patients. Bronchoscopy with bronchoalveolar lavage (BAL) is often used…”
Get full text

Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease by Baah, Samantha, Gorgone, Matthew, Lachant, Daniel

“…Necrotizing autoimmune myopathy (NAM) is a rare inflammatory process characterized by bilateral proximal muscle weakness and elevated creatinine kinase levels…”
Get full text

Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertension by Arevalo, Carlo, White, R.James, Lachant, Daniel

“…There are no prospective studies or guidelines describing transition between selexipag and oral treprostinil. We present two different transition strategies…”
Get full text

Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli by Lachant, Daniel J, Bach, Christina, Fe, Alexander, White, R James, Lachant, Neil A

“…There is little reported on the efficacy and safety of direct oral anticoagulants (DOACs) in morbid obesity after venous thromboembolism (VTE). In this…”
Get full text

Angiopoietin-2 and D-dimer add prognostic information to clinical risk in pulmonary arterial hypertension by Clark, Heather L., Lachant, Daniel, Light, Allison N., Haight, Deborah, Lopia, Samia, Mackman, Nigel, White, R. James

“…Thrombosis and endothelial injury are pathologic hallmarks of pulmonary arterial hypertension (PAH). We aimed to evaluate whether markers of endothelial…”
Get full text

Evaluation of Clinical Recovery After Surgical Treatment for Hand Ischemia From Vasospastic and Occlusive Disease Using PROMIS by Bernstein, David N., Cliburn, John A., Lachant, Daniel J., White, R. James, Hammert, Warren C.

“…Background There is a paucity of literature describing the recovery trajectory after surgery for upper extremity ischemia. Using Patient-Reported Outcomes…”
Get full text

Heart rate monitoring improves clinical assessment during 6-min walk by Lachant, Daniel J., Light, Allison, Offen, Melissa, Adams, Jamie, White, R. James

“…Right ventricular (RV) function is a predictor of outcomes in pulmonary arterial hypertension (PAH). The 6-min walk test (6MWT) is likely an indirect measure…”
Get full text

The clinical impact of pneumocystis and viral PCR testing on bronchoalveolar lavage in immunosuppressed patients by Lachant, Daniel J., Croft, Daniel P., McGrane Minton, Heather, Hardy, Dwight J., Prasad, Paritosh, Kottmann, R. Matthew

“…Pulmonary infiltrates in immunosuppressed patients are common. Yields from bronchoscopy with bronchoalveolar lavage (BAL) has been reported to be between 31…”
Get full text

Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension by Lachant, Daniel, Light, Allison, Lachant, Michael, Annis, Jeffrey, Hemnes, Anna, Brittain, Evan, White, R James

“…Pulmonary arterial hypertension (PAH) patients have low activity. Activity intensity or duration could be a measure of clinical status or improvement. We aimed…”
Get full text

Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats by Lachant, Daniel J., Meoli, David F., Haight, Deborah, Lyons, Jason A., Swarthout, Robert F., White, R. James

“…Purpose/Aim: Low doses (30-80 mg/kg) of monocrotaline are commonly used to create experimental models of pulmonary hypertension in rats. At these doses,…”
Get full text

Pulmonary perfusion defects or residual vascular obstruction and persistent symptoms after pulmonary embolism: a systematic review and meta-analysis by Cimini, Ludovica Anna, Luijten, Dieuwke, Barco, Stefano, Ghanima, Waleed, Jervan, Øyvind, Kahn, Susan R, Konstantinides, Stavros, Lachant, Daniel, Nakano, Yoshihisa, Ninaber, Maarten, van Es, Josien, van Mens, Thijs, Vonk Noordegraaf, Anton, Becattini, Cecilia, Klok, Frederikus A

“…Up to 50% of pulmonary embolism (PE) patients have perfusion defects or residual vascular obstruction during follow-up despite adequate anticoagulant…”
Get full text